期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Feasibility study of cyclodextrins as active pharmaceutical ingredients for the treatment of GM1-gangliosidosis
1
作者 Yuki Maeda Keiichi Motoyama +10 位作者 Taishi Higashi Yuka Horikoshi Toru Takeo Naomi Nakagata Yuki Kurauchi Hiroshi Katsuki Yuki Kondo Yoichi Ishitsuka Tetsumi Irie takumi erad Hidetoshi Arima 《Asian Journal of Pharmaceutical Sciences》 SCIE CAS 2016年第1期183-184,共2页
GM1-gangliosidosis is a rare lysosomal storage disorder characterized clinically by a wide range of variable neurovisceral,ophthalmological and dysmorphic features. Without enough functionalβ-galactosidase, GM1-gangl... GM1-gangliosidosis is a rare lysosomal storage disorder characterized clinically by a wide range of variable neurovisceral,ophthalmological and dysmorphic features. Without enough functionalβ-galactosidase, GM1-gangliosides cannot be degraded in lysosomes, and accumulate to toxic levels in many tissues and organs, particularly in the brain. In spite of several approaches for the treatment of GM1-gangliosidosis. 展开更多
关键词 Cyclodextrins GM1-gangliosidosis Fibroblasts Lysosomes
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部